CClinicalTrials.gg
Status unknownNCT04491201CMDA-SURVEY2Updated Jul 29, 2020

National Survey of the Impact of COVID-19 Pandemics

An observational study in COVID-19 Pandemics, Obstetrics and Gynecology and Workload, sponsored by Lei Li. Status unknown at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-07-29.

Sponsored by Lei Li · Observational

The sponsor has not verified this record recently (last verified Jul 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
6,000
Ages
18 Years and older
Sex
All
01

Study summary

COVID-19 pandemics have changed extensively the lives around the world. Although most physicians of obstetrics and gynecology have no critical role in the frontline against COVID-19 pandemics, their work, research and education activities still underwent great changes. The primary aim of this study is to analyze change of workload during the COVID-19 pandemics in physicians of obstetrics and gynecology in China. A customized questionnaire will be delivered by the social software WeChat to the specific hospital which has been randomly sampled, and all physicians of Obstetrics and Gynecology in this hospital will fill the questionnaire anonymously.

A random sampling will be performed in all 32 provinces, municipality or autonomous regions in the mainland of China. It is assumed that acceptable 95% confidence interval is P±4%, and the sample size under the condition of simple random sampling is 600 persons. If the homogeneity is set as 0.15 or 0.2, and each population (unit) has 10 or 15 persons accepting survey, we will achieve a design effect of 2.35 to 3.80. If we choose the design effect of 3, the sample size of every level needs is 1800. Considering 10% population refusing to be surveyed, in all mainland of China, three levels of hospitals will include at least 6000 physicians who accept survey.

02

Conditions studied

  • COVID-19 Pandemics
  • Obstetrics and Gynecology
  • Workload
  • Questionnaire
  • National Survey
  • China

Browse trials for

03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's planned enrollment of 6,000 is above the median of 260 across 3,135 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Lei Li is the lead sponsor of 60 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

All physicians of obstetrics and gynecology from the hospitals randomly sampled

Inclusion criteria

  • Aged 18 years old
  • Belonging to and registered at specific hospital
  • Active employment in obstetrics, reproduction, or gynecology
  • Signed an approved informed consents

Exclusion criteria

Exclusion Criteria:

  • Not meeting all the inclusion criteria
  • Not completing the whole questionnaire
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
6,000 participants (estimated)
Patient registry
No

Interventions

  • OtherCustomized questionnaire

    A customized questionnaire will be delivered by the social software WeChat to the specific hospital which has been randomly sampled, and all physicians of Obstetrics and Gynecology in this hospital will fill the questionnaire anonymously.

06

What researchers measure

Primary outcomes

  1. The changes of workload of physicians during COVID-19 pandemics compared with 2019 year

    Reduction or augment in percentage of workload including outpatient clinics, surgeries, counseling and deliveries

    Time frame: Six months

Secondary outcomes

  1. The changes of education activities during COVID-19 pandemics compared with 2019 year

    Reduction or augment in percentage of education activities including lectures, ward rounds and exams.

    Time frame: Six months

  2. The changes of research activities during COVID-19 pandemics compared with 2019 year

    Reduction or augment in percentage of research activities including research protocol advancement, paper composition/submission/publication, and fund application

    Time frame: Six months

07

Study locations

1 of 1 sites recruiting
  • Lei Li
    Beijing, Beijing 100730, China
    Recruiting
08

References and documents

Publications

  • Li L, Cao Y, Fan J, Li T, Lang J, Zhang H, Lv J, Zhu L; Chinese Medical Doctor Association. Impact of COVID-19 Pandemic on the Clinical Activities in Obstetrics and Gynecology: A National Survey in China. Front Med (Lausanne). 2021 Jul 30;8:633477. doi: 10.3389/fmed.2021.633477. eCollection 2021. PubMed 34395457 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 29, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04491201
Lead sponsor
Lei Li
Responsible party
Lei Li (Professor, Peking Union Medical College Hospital) — Sponsor-investigator
First posted
Jul 29, 2020
Start date
Jul 27, 2020
Primary completion
Sep 27, 2020 (estimated)
Completion
Sep 27, 2020 (estimated)
Last update
Jul 29, 2020

Study contacts

Lei Li, M.D.
Contact
lileigh@163.com
86-139-1198-8831
Lei Li, M.D.
principal investigator · Peking Union Medical College Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion